Apellis Pharmaceuticals
APLS
#2958
Rank
S$5.76 B
Marketcap
$46.36
Share price
-1.48%
Change (1 day)
-37.88%
Change (1 year)

EPS for Apellis Pharmaceuticals (APLS)

EPS in 2023 (TTM): -$7.06

According to Apellis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$7.15. In 2022 the company made an earnings per share (EPS) of -$8.35 an increase over its 2021 EPS that were of -$12.06.

EPS history for Apellis Pharmaceuticals from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.06-15.44%
2022-$8.35-30.73%
2021-$12.0692.81%
2020-$6.26-11.73%
2019-$7.09123.18%
2018-$3.1827.08%
2017-$2.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.97-58.48%๐Ÿ‡บ๐Ÿ‡ธ USA